Gonorrhea is a big problem among men who have sex with men (MSM) in the UK. A vaccine could help, but how do we make sure it reaches the right people without breaking the bank? This is a tricky question. Some methods have been tried before, but they have their issues. For example, giving the vaccine
Getting more steps into the day can add years to life, but how to motivate people to move more? That is the question. A recent study looked at three ways to boost physical activity among folks at risk for heart trouble. The methods were gamification, money rewards, or a mix of both. The goal was
Every year, influenza sweeps through France, leading to over 1 million visits to doctors, 20, 000 hospital stays, and sadly, around 9, 000 deaths. This virus doesn't discriminate, but it does hit some groups harder than others. Adults aged 50 and over are at a higher risk. Why? As people age, they o
The 100, 000 Genomes Project is a big deal in the world of genetics. It's all about sequencing genomes to find extra bits of information. This isn't just about finding out what makes us unique. It's also about discovering health risks that people might not know they have. But there's a catch. Return
In many developing countries, tuberculosis (TB) often goes undetected or is diagnosed too late. This delay leads to unnecessary suffering, deaths, and further spread of the disease. One promising solution is decentralized testing, which brings accurate TB diagnosis closer to where people live. The T
Brazil is preparing for a potential outbreak of foot-and-mouth disease (FMD). This virus can cause big problems. It can lead to the loss of many animals, lower the production of livestock and meat, and increase spending on control and eradication. Plus, it can lead to trade restrictions, which can h
The financial impact of cancer treatments goes far beyond the cost of the drugs themselves. Side effects from these treatments can rack up significant bills, and if these costs are not accurately measured, it can skew the overall assessment of a treatment's value. The extra costs from side effe
In January 2024, Chinese officials gave the green light to nirsevimab. This drug is designed to shield infants from respiratory syncytial virus (RSV). In Shanghai, researchers wanted to see if using nirsevimab for babies was a good deal. They looked at two plans: giving the shot all year or just dur
Cholesterol is a big deal. It plays a huge role in heart health. High levels of the bad kind, called LDL, can lead to serious heart problems. Doctors often prescribe atorvastatin to help manage this. It's effective, but the original brand can be pricey. Now, there's a second generic version on the m
Let's dive into the world of kidney disease treatment. Two main options exist for people with failing kidneys: home dialysis and in-center dialysis. Home dialysis, done daily, has some clear benefits. It can improve a person's quality of life and offer more flexibility in scheduling. However, the co
